Position in NVS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$673,582
+$13,550 QoQ
Shares Held
4,298
-0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#764
of 1,602 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First City Capital Management, Inc. holds $23,745,475 across 11 Drug Manufacturers - General names. NVS ranks #9 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,107 | $7,324,919 | |
| 2 | ABBV |
AbbVie Inc.
|
24,295 | $6,113,593 | |
| 3 | JNJ |
Johnson & Johnson
|
10,712 | $2,720,526 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,988 | $2,311,458 | |
| 5 | AMGN |
Amgen Inc
|
3,282 | $1,188,477 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,427 | $1,119,383 | |
| 7 | PFE |
Pfizer Inc
|
35,814 | $862,401 | |
| 8 | AZN |
Astrazeneca PLC
|
3,619 | $686,234 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $673,582 | 4,298 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $660,032 | 4,321 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $595,598 | 4,320 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $566,820 | 4,420 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $558,340 | 4,614 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $522,729 | 4,689 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $450,156 | 4,626 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $616,622 | 5,361 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $568,070 | 5,336 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $516,054 | 5,335 | Shares | Sole | 2024-05-22 | |
| 2023-09-30 | $566,137 | 5,558 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $560,857 | 5,558 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $529,736 | 5,758 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $499,685 | 5,508 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $437,665 | 5,758 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $489,259 | 5,788 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $507,897 | 5,788 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $493,068 | 5,637 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $557,085 | 6,812 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $621,526 | 6,812 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $522,026 | 6,107 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $577,628 | 6,117 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $883,774 | 10,163 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $494,519 | 5,662 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $446,136 | 5,411 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||